Global Intravenous Therapy (IV) Market Segmentation, By Material Type (Polypropylene, Polyvinyl Chloride, Polyethylene, Copolyester Ether, and EVA), Capacity (0-250 ml, 250-500ml, 500-1000 ml, and Above 1000 ml), Chamber Type (Single Chamber and Multi Chamber), Application (Parenteral Nutrition and Intravenous Therapies) – Industry Trends and Forecast to 2031.
Intravenous Therapy (IV) Market Analysis
The substantial volume of major surgeries performed globally each year acts as a significant driver for growth in the intravenous (IV) therapy market. According to the National Library of Medicine, part of the National Institutes of Health (NIH), approximately 310 million major surgeries are conducted worldwide annually. In the U.S. alone, this figure ranges from 40 to 50 million, with Europe contributing around 20 million procedures. This high frequency of surgical interventions necessitates robust and reliable IV therapy solutions. IV therapy is critical during surgeries for administering anesthetics, fluids, medications, and nutrients directly into the bloodstream, ensuring that patients remain stable and recover efficiently. The sheer scale of surgical procedures across various regions underscores the ongoing demand for advanced IV products, including infusion pumps, IV fluids, and catheter systems, to support these medical activities.
Intravenous Therapy (IV) Market Size
Global intravenous therapy (IV) market size was valued at USD 2.47 million in 2023 and is projected to reach USD 4.01 million by 2031, with a CAGR of 6.25% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Intravenous Therapy (IV) Market Trends
“Rising Prevalence of Dehydration and Malnutrition”
The increasing rates of dehydration and malnutrition, especially in areas where access to clean water, nutritious food, and medical care is limited, is significantly influencing the demand for intravenous (IV) therapy. These individuals are more susceptible to conditions that necessitate immediate and effective intervention. IV therapy plays a crucial role in addressing these issues by offering a reliable method for rapid rehydration and nutrient delivery. For patients suffering from severe dehydration due to illnesses, malnutrition, or lack of access to adequate hydration, IV therapy provides a means to restore essential fluid levels and administer vital nutrients directly into the bloodstream. This intervention is not only life-saving but also critical for the recovery of individuals in dire health situations. As the global focus on improving healthcare access and combating malnutrition intensifies, the demand for IV therapy solutions is expected to rise. This trend underscores the need for ongoing investment in IV technologies and infrastructure to better address the healthcare challenges associated with dehydration and malnutrition in vulnerable populations.
Report Scope and Intravenous Therapy (IV) Market Segmentation
|
Attributes
|
Intravenous Therapy (IV) Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Key Market Players
|
Baxter (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), Pfizer Inc. (U.S.), Terumo Group (Japan), B. Braun SE (Germany), Technoflex (France), and Macopharma (France)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
|
Intravenous Therapy (IV) Market Definition
Intravenous therapy (IV) is a medical treatment in which fluids, medications, or nutrients are administered directly into a patient's bloodstream through a vein. This method allows for rapid and efficient delivery of substances into the body, bypassing the digestive system and ensuring that the treatment is quickly available to the body’s tissues. The procedure typically involves inserting a needle or catheter into a vein, often in the arm or hand, through which the fluids or medications are delivered.
Intravenous Therapy (IV) Market Dynamics
Drivers
- Rising Incidence of Chronic Diseases
The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is significantly driving the demand for intravenous (IV) therapy. As these conditions often require long-term and continuous treatment, IV therapy becomes a crucial method for administering medications, nutrients, and fluids directly into the bloodstream, ensuring fast and effective management of these health issues. The growth in chronic disease cases worldwide underscores the importance of IV therapy in modern healthcare, leading to a continuous rise in its adoption across various medical settings.
- Growing Demand for Home Healthcare
The rise in home healthcare services is fueling the need for portable and user-friendly IV devices. As more patients seek to receive medical care in the comfort of their homes, the demand for IV therapy devices that are easy to use, reliable, and suitable for non-hospital environments has surged. These devices allow patients to manage their treatment effectively at home, reducing the need for hospital visits and lowering overall healthcare costs. The convenience and efficiency offered by home IV therapy are key factors driving the expansion of this market segment.
Opportunities
- Development of Portable IV Devices
There is substantial growth potential in the development of portable and wearable IV devices. These innovations are particularly beneficial for patients who require continuous or long-term intravenous therapy but wish to maintain mobility and independence. Portable IV devices are designed to be lightweight, compact, and easy to use, making them ideal for home healthcare, outpatient settings, and even for patients who need to continue their treatment while on the move. The increasing focus on patient convenience is expected to drive further advancements and adoption in this area.
- Focus on Infection Control Solutions
The development of advanced infection control solutions is becoming increasingly important in the IV therapy market. Solutions such as antimicrobial coatings on IV devices and closed system transfer devices (CSTDs) are designed to minimize the risk of infections and other complications associated with intravenous therapy. These innovations are critical in enhancing patient safety and improving overall treatment outcomes. As infection control becomes a priority in healthcare settings, the demand for these advanced solutions is expected to grow, driving market expansion.
Restraints/Challenges
- High Costs of Advanced IV Devices
The high costs associated with advanced IV therapy devices and technologies can pose a significant barrier to market growth. Innovations such as smart infusion pumps and specialized catheters often come with higher price tags, making them less accessible for smaller healthcare facilities and patients in lower-income regions. The affordability of these devices remains a key concern, potentially limiting their widespread adoption and slowing down market expansion, especially in developing countries.
- Risk of Complications
The risk of complications related to IV therapy, such as vein thrombosis and catheter-related issues, presents challenges to its widespread adoption. These potential complications can lead to serious health risks, increased treatment costs, and longer hospital stays, making healthcare providers and patients cautious about the use of IV therapy. Addressing these risks through improved device design, better training for healthcare professionals, and the development of safer materials is essential to overcoming these barriers and promoting the broader use of IV therapy.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Global Intravenous Therapy (IV) Market Scope
The market is segmented on the basis of type, application, sales channel, material, roller diameter, roller width, and farming scale. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Material Type
- Polypropylene
- Polyvinyl Chloride
- Polyethylene
- Copolyester Ether
- EVA
Capacity
- 0-250 ml
- 250-500 ml
- 500-1000 ml
- Above 1000 ml
Chamber Type
- Single Chamber
- Multi Chamber
Application
- Parenteral Nutrition
- Intravenous Therapies
Global Intravenous Therapy (IV) Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country, material type, capacity, chamber type and application as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the growing adoption of innovative healthcare technologies, the strong presence of key industry players, and the high prevalence of conditions such as cancer, vomiting, and diarrhea. The region also benefits from a well-established healthcare infrastructure and an increasing number of research partnerships, further contributing to its market dominance.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Global Intravenous Therapy (IV) Market Share
The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Intravenous Therapy (IV) Market Leaders Operating in the Market Are:
- Baxter (U.S.)
- Fresenius SE & Co. KGaA (Germany)
- ICU Medical, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Terumo Group (Japan)
- B. Braun SE (Germany)
- Technoflex (France)
- Macopharma (France)
SKU-